PetVivo Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PETV research report →
About the company
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines.
- CEO
- John Lai
- IPO
- 2014
- Employees
- 20
- HQ
- Minneapolis, MN, US
Price Chart
- Market Cap
- $25.21M
- P/E
- -2.31
- P/S
- 22.08
- P/B
- 13.43
- EV/EBITDA
- -2.86
- Div Yield
- 0.00%
- Gross Margin
- 66.11%
- Op Margin
- -706.28%
- Net Margin
- -917.45%
- ROE
- -310.51%
- ROIC
- -313.05%
- Revenue
- $1.14M · 0.80%
- Net Income
- $-10,473,672 · -24.70%
- EPS
- $-0.36 · 12.20%
- Op Income
- $-8,062,962
- FCF YoY
- -3.90%
- 52W High
- $1.69
- 52W Low
- $0.60
- 50D MA
- $0.79
- 200D MA
- $0.96
- Beta
- 1.24
- Avg Volume
- 8.76K
Get TickerSpark's AI analysis on PETV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | A.L. Sarroff Fund, LLC | buy | 187,500 |
| Jun 9, 26 | A.L. Sarroff Fund, LLC | buy | 187,500 |
| May 28, 26 | A.L. Sarroff Fund, LLC | other | 200,000 |
| May 22, 26 | A.L. Sarroff Fund, LLC | buy | 250,000 |
| May 15, 26 | LOWENTHAL GARRY N | other | 66,421 |
| May 15, 26 | Lai John | other | 66,421 |
| Apr 15, 26 | Rudelius Robert James | other | 50,000 |
| Mar 23, 26 | A.L. Sarroff Fund, LLC | buy | 1,000 |
| Mar 23, 26 | A.L. Sarroff Fund, LLC | buy | 23,033 |
| Mar 9, 26 | Rudelius Robert James | other | 35,000 |
Our PETV coverage
Recent articles, reports, and earnings notes.
No research on PETV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PETV report →Similar companies
Peers in the same neighborhood.